MELBOURNE, Australia and SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
- Data Presented at the International Congress of Parkinson’s Disease and Movement Disorders - The posters presented from Alterity’s bioMUSE study address the need for incorporating biomarkers as a ...
Researchers from Asan Medical Center, one of South Korea's largest hospitals, have developed a generative AI model that can autonomously learn and analyse brain scans to diagnose and predict the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results